Thrombectomy procedures allow surgeons to use a mechanical thrombectomy device such as intracoronary catheters to break up or remove the blood clot and restore normal blood flow in the human body. It helps neurosurgeons to improve patients’ health, especially those experiencing a large artery stroke. Thrombectomy is widely used in major economies of Asia Pacific such as China, India, Australia, and others, due to high number of stroke incidences and increased spending in healthcare. Thrombectomy devices can be used in patients for whom pharmacological treatments such as thrombolysis are likely to be ineffective or inappropriate, for instance, in case of recent surgery or in patients who are taking oral anticoagulants.

Market Dynamics

Thrombectomy devices are used to treat blood clots present in the arteries, veins, and capillaries. Thrombectomy devices are carefully designed to minimize damage to the vessel wall during a blood clot removal procedure, with minimum blood loss. The rising demand for minimally invasive thrombectomy procedures is expected to drive the growth of the global thrombectomy devices market. For instance, as per a publication by the American Heart Association (AHA) Journals in 2020, patients with COVID-19 suffer from a number of cardiovascular complications, including 16.7% patients suffer from arrhythmia and 23% of patients suffer from heart failure, thus increasing risk for acute ischemic stroke. Cerebrovascular complications have been reported in 5% to 6% of patients with severe COVID-19, globally. This has increased concerns to improve the accessibility and shorten the time to endovascular therapy (EVT) for stroke to give patients better outcome after strokes.

Key features of the study

• This report provides in-depth analysis of the global thrombectomy devices market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global thrombectomy devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include LeMaitre Vascular, Inc., Boston Scientific Corporation, Control Medical Technology, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic Plc., Merit Medical Systems, Inc., Stryker Corporation, Terumo Corporation, Penumbra, Inc., Argon Medical Devices, Teleflex Incorporated, and Vetex Medical Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global thrombectomy devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global thrombectomy devices market.

Market Segmentation

• By Product Type
  • Mechanical Thrombectomy Devices
  • Aspiration Thrombectomy Devices
  • Hydrodynamic Thrombectomy Devices
  • Ultrasonic Thrombectomy Devices
• By Application
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Superficial Vein Thrombosis
  • Renal Vein Thrombosis (RVT)
  • Arterial Thrombosis (Atherothrombosis)
  • Others (Ischemic Stroke, etc.)
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others (Academic and Research Institutes, etc)
• By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players
  • Boston Scientific Corporation
  • Medtronic
  • Merit Medical System Inc.
  • Stryker Corporation
  • Terumo Corporation
  • Teleflex Incorporated
  • Vetex Medical Ltd.
  • Edwards Lifesciences Corporation
  • Penumbra Inc.
  • Control Medical Technology LLC.
  • Rapid Medical
  • Abbott
  • Surmodics, Inc.